2 terminated, 1 completed. 2 Phase 2, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Mohit Khera: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypoactive Sexual Desire Disorder in Males Flibanserin, Placebo - Low Libido | Phase 2 | Terminated | Mohit Khera | 8 | 2020-05-08 | 2026-01-26 |
| H-22411: BOTOX® for Peyronie's Disease 100 units of Botulinum Toxin Type A, Preservative free normal saline, 100 units Botulinum Toxin A - Peyronie's Disease | Phase 2 | Completed | Mohit Khera | 12 | 2009-08-07 | 2024-04-08 |
| Testosterone for Penile Rehabilitation After Radical Prostatectomy Testim®, Placebo Testim®, Viagra® - Hypogonadism, Erectile Dysfunction | Early Phase 1 | Terminated | Mohit Khera | 3 | 2007-11-01 | 2015-06-19 |
Erectile Dysfunction (2) · Hypogonadism (1) · Penile Induration (1)
Botulinum Toxins, Type A (1) · Crossing Over, Genetic (1) · Sildenafil Citrate (1) · Testosterone (1) · flibanserin (1)
United States (3)